US Cancer Burden Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.

Slides:



Advertisements
Similar presentations
Preventing Cancer with Healthy Life Styles Li-Fen L. Chang, M.D., Ph.D. Radiation Oncology SOMC Cancer Center.
Advertisements

Iowa Cancer Facts & Figures 2012 Cancer Data Update.
Translational Cancer Research From Laboratory to Practice William J Catalona MD Professor of Urology Director, Clinical Prostate Cancer Program Northwestern.
Professor of Hematology, Oncology, Medicine and Epidemiology
An Introduction to Cancer Biology Geoff Mitchell April 24, 2007.
EPIDEMIOLOGIA – GENERALITA’ L’incidenza (o morbidità) si riferisce alla percentuale di popolazione in cui si sviluppa la malattia durante un dato periodo.
April 6, o What is cancer? o Cancer statistics o Cancer prevention and early detection o Cancer disparities o Cancer survivorship o Cancer research.
Tuesday, June 23, Today’s discussion General cancer statistics Cancer in Canada PEI Statistics at a glance Impact.
1 Cancer PREVENTION “Take charge of your life and learn as much as you can about illness. Knowledge generates hope.” Lance Armstrong Winner of 6 Tour de.
Otis W. Brawley, M.D. Chief Medical and Scientific Officer Executive Vice President American Cancer Society Professor of Hematology, Medical Oncology,
Colorectal cancer: How do we approach health disparities? Marta L. Davila, MD, FASGE University of Texas MD Anderson Cancer Center.
Cancer Statistics 2013 A Presentation from the American Cancer Society
Dietary intakes of calcium and vitamin D and risk of colorectal cancer in women Jennifer Lin, PhD Division of Preventive Medicine Brigham and Women’s Hospital.
Life expectancy at birth NOTE: Life expectancy data by Hispanic origin were available starting in SOURCE: CDC/NCHS, Health, United States, 2014,
Men’s Health- Prostate and Colorectal Cancer 2010.
Healthy People 2010 Focus Area 3 Cancer Progress Review October 16, 2002.
A Strategic Approach to the Control of Cancer Otis W. Brawley, M.D. Chief Medical and Scientific Officer American Cancer Society Professor of Hematology,
Health Disparities From knowledge to action. Overview of Disparities Ethnicity Socioeconomic Status Geographic location.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
Cancer Statistics 2013 A Presentation from the American Cancer Society
YOU HAVE A CHOICE! Dr S Andaz MD, FACS, FRCS Director Center for Minimally Invasive Thoracic Surgery and Thoracic Surgical Oncology South Nassau Hospital.
Cancer Epidemiology and Cancer Prevention Epidemiology 242 December 2, 2009.
MOLLY SCHWENN, MD CANCER REGISTRY MAINE CDC, DHHS OCTOBER 25, 2013 Population-based Cancer Surveillance: State Perspective.
Health Report on Cancer Bryan Gregory (Extra Credit Presentation)
Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.
Cell Culture Forensics. S. O’brien PNAS July 3, 2001 vol. 98 no Henrietta Lacks Cancer: Detection and Treatment.
Cervical Cancer in California Janet Bates, MD MPH Research Program Director Research and Surveillance Program California Cancer Registry.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
BIOE 301 Lecture Twelve Jair Martinez Bioengineering Department Rice University.
Cancer Incidence and Mortality in Massachusetts, Bureau of Health Statistics, Research and Evaluation Massachusetts Department of Public Health.
Prostate Screening in 2009: New Findings and New Questions Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancer.
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
Cell Cycle Regulation and Cancer. 3 Checkpoints Control the cell cycle (inspection points) Make sure the cell is ready to move into the next phase. Mitosis.
Regulating the Cell Cycle Biology 392 Chapter 10-3.
Breast Cancer: Treatment or Not? HFE 742 Cathy Simmons November 10, 2005.
WE WILL ALL DIE OF CANCER If something else doesn’t kill us first HYPOTHESIS:
Lecture Twelve Biomedical Engineering for Global Health.
Cell Culture Forensics. S. O’brien PNAS July 3, 2001 vol. 98 no Henrietta Lacks Cancer: Causes and Treatment.
THE CELL CYCLE AND CANCER. Control of the Cell cycle Control of the cell cycle.
Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013.
BME 301 Lecture Twelve.
 Group of diseases characterized by abnormal cell growth and replication.  Precancerous cells often are destroyed by the immune system.  If not destroyed,
The Genetic Component of a Common Disease The Paradigm of Cancer Genetics John Quillin, PhD, MPH, MS Virginia Commonwealth University Summer, 2006.
Cell Culture Forensics. S. O’brien PNAS July 3, 2001 vol. 98 no Henrietta Lacks Cancer: Detection and Treatment.
Bioengineering and World Health Lecture Twelve. Four Questions What are the major health problems worldwide? Who pays to solve problems in health care?
Homework #3 is due 11/19 Bonus #2 is posted. Cancer: is the loss of control over cell division. Tumors are normal cells that are dividing inappropriately.
Healthy People 2010 Focus Area 3 Cancer Progress Review October 16, 2002.
Healthy People 2010 Focus Area 3: Cancer Progress Review August 17, 2006.
Cell Cycle Regulation and Cancer. 3 Checkpoints Control the cell cycle (inspection points) Make sure the cell is ready to move into the next phase. Mitosis.
Riva L. Rahl, M.D. Cooper Clinic Preventive Medicine Physician Medical Director, Cooper Wellness Program Cancer: Beating the Odds.
The American Cancer Society recommends these cancer screening guidelines for most adults. Screening tests are used to find cancer before a person has.
Cancer: causes abnormal and uncontrolled cell growth to occur within body Because cancer cells continue to grow and divide, they are different from normal.
Cell Division Mitosis. Why do they have to be so small? Why not keep growing – why divide? Surface area to Volume ratio Too much volume, too little space.
Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,
2007 Pitt County Community Health Assessment Review of Secondary Data September 13, 2007.
What is cancer?. Cancer Development of abnormal cells Divide uncontrollably Can infiltrate and destroy normal body tissue.
The Importance of Preventative Care
A Presentation From the American Cancer Society
Cervical Cancer in California
US Mortality, 2003 No. of deaths % of all deaths Rank Cause of Death
Non-Communicable Diseases Lesson 7
Cancer Prevention Screening and Early Detection PROF.MAZIN AL-HAWAZ.
Cancer Epidemiology Kara P. Wiseman, MPH, Phd
American Cancer Society Guidelines for the Early Detection of Cancer
Presentation transcript:

US Cancer Burden Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009

US Mortality, 2006 *Includes nephrotic syndrome and nephrosis. Source: US Mortality Data 2006, National Center for Health Statistics, Centers for Disease Control and Prevention, Heart Diseases631, Cancer559, Cerebrovascular diseases137, Chronic lower respiratory diseases124, Accidents (unintentional injuries)121, Diabetes mellitus 72, Alzheimer disease 72, Influenza & pneumonia 56, Nephritis* 45, Septicemia 34, RankCause of Death No. of deaths % of all deaths

Change in US Death Rates* from 1991 to 2006 * Age-adjusted to 2000 US standard population. Sources: US Mortality Data, National Center for Health Statistics, Centers for Disease Control and Prevention, Rate Per 100,000

Age Standardized Incidence Rates US More developed countries Less developed countries SiteMalesFemalesMalesFemalesMalesFemales Lung Breast─101.1─67.8─23.8 Colon/Rectum Stomach Liver Prostate124.8─56.2─9.4─ Cervix─7.7─10.3─19.1 Esophagus Source: GLOBOCAN 2002

Ten Leading Cancer Types for New Cancer Cases 2009 Estimates Number of New Cases SiteBothMaleFemale Lung & Bronchus219,440116,090103,350 Breast194,2801,910192,370 Prostate192, Colon/Rectum146,97075,59071,380 Bladder70,98052,81018,170 Skin Melanoma68,72039,08029,640 Non-Hodgkin Lymphoma65,98035,99029,990 Kidney57,76035,43022,330 Leukemia44,79025,63019,160 Pancreas42,47021,05021,420 All Sites1,479,350766,130713,220

2009 Estimated US Cancer Cases* *Excludes basal and squamous cell skin cancers and in situ carcinomas except urinary bladder. Source: American Cancer Society, Men 766,130 Women 713,220 27%Breast 14%Lung & bronchus 10%Colon & rectum 6%Uterine corpus 4%Non-Hodgkin lymphoma 4%Melanoma of skin 4% Thyroid 3%Kidney & renal pelvis 3%Ovary 3%Pancreas 22%All Other Sites Prostate25% Lung & bronchus15% Colon & rectum10% Urinary bladder7% Melanoma of skin5% Non-Hodgkin5% lymphoma Kidney & renal pelvis5% Leukemia 3% Oral cavity3% Pancreas3% All Other Sites19%

Cancer Incidence Rates* by Sex, US, *Age-adjusted to the 2000 US standard population and adjusted for delays in reporting. Source: Surveillance, Epidemiology, and End Results Program, Delay-adjusted Incidence database: SEER Incidence Delay-adjusted Rates, 9 Registries, , National Cancer Institute, Both Sexes Men Women Rate Per 100,000

Cancer Incidence Rates* Among Men, US, Prostate Lung & bronchus Colon and rectum Urinary bladder Non-Hodgkin lymphoma Rate Per 100,000 Melanoma of the skin *Age-adjusted to the 2000 US standard population and adjusted for delays in reporting. Source: Surveillance, Epidemiology, and End Results Program, Delay-adjusted Incidence database: SEER Incidence Delay-adjusted Rates, 9 Registries, , National Cancer Institute, 2008.

Cancer Incidence Rates* Among Women, US, *Age-adjusted to the 2000 US standard population and adjusted for delays in reporting. Source: Surveillance, Epidemiology, and End Results Program, Delay-adjusted Incidence database: SEER Incidence Delay-adjusted Rates, 9 Registries, , National Cancer Institute, Colon and rectum Rate Per 100,000 Breast Lung & bronchus Uterine Corpus Ovary Non-Hodgkin lymphoma

Cancer Incidence Rates* by Race and Ethnicity, *Age-adjusted to the 2000 US standard population. † Person of Hispanic origin may be of any race. Source: Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Sciences, National Cancer Institute, Rate Per 100,000

Cancer Incidence Rates* by Sex and Race, US, *Age-adjusted to the 2000 US standard population. Source: Surveillance, Epidemiology, and End Results Program, Delay-adjusted Incidence database: SEER Incidence Delay-adjusted Rates, 9 Registries, , National Cancer Institute, African American men White men White women African American women Rate Per 100,000

Ten Leading Cancer Types for Cancer Deaths 2009 Estimates Number of Deaths SiteBothMaleFemale Lung & Bronchus159,39088,90070,490 Colon/Rectum49,92025,24024,680 Breast40, ,170 Pancreas35,24018,03017,210 Prostate27, Leukemia21,87012,5909,280 Non-Hodgkin Lymphoma19,5009,8309,670 Liver18,16012,0906,070 Ovary14, ,600 Esophagus14,53011,4903,040 All Sites562,340292,540269,800

2009 Estimated US Cancer Deaths* ONS=Other nervous system. Source: American Cancer Society, Men 292,540 Women 269,800 26%Lung & bronchus 15%Breast 9%Colon & rectum 6%Pancreas 5%Ovary 4%Non-Hodgkin lymphoma 3%Leukemia 3%Uterine corpus 2% Liver & intrahepatic bile duct 2%Brain/ONS 25% All other sites Lung & bronchus30% Prostate9% Colon & rectum 9% Pancreas6% Leukemia4% Liver & intrahepatic4% bile duct Esophagus4% Urinary bladder3% Non-Hodgkin 3% lymphoma Kidney & renal pelvis3% All other sites 25%

Cancer Death Rates* by Sex, US, *Age-adjusted to the 2000 US standard population. Source: US Mortality Data , National Center for Health Statistics, Centers for Disease Control and Prevention, Men Both Sexes Rate Per 100,000 Women

Trends in the Number of Cancer Deaths Among Men and Women, US, Women Men Number of Cancer Deaths Men Women Source: US Mortality Data, , National Center for Health Statistics, Centers for Disease Control and Prevention, 2009.

Cancer Death Rates* Among Men, US, *Age-adjusted to the 2000 US standard population. Source: US Mortality Data , US Mortality Volumes , National Center for Health Statistics, Centers for Disease Control and Prevention, Lung & bronchus Colon & rectum Stomach Rate Per 100,000 Prostate Pancreas LiverLeukemia

Cancer Death Rates* Among Women, US, *Age-adjusted to the 2000 US standard population. Source: US Mortality Data , US Mortality Volumes , National Center for Health Statistics, Centers for Disease Control and Prevention, Lung & bronchus Colon & rectum Uterus Stomach Breast Ovary Pancreas Rate Per 100,000

*Per 100,000, age-adjusted to the 2000 US standard population. † Persons of Hispanic origin may be of any race. Source: Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Sciences, National Cancer Institute, Cancer Death Rates* by Race and Ethnicity, US,

African American men White men African American women White women Rate Per 100,000 Cancer Death Rates* by Sex and Race, US, *Age-adjusted to the 2000 US standard population. Source: Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Sciences, National Cancer Institute, 2008.

All sites Prostate Larynx Stomach Myeloma Oral cavity and pharynx Small intestine Liver and intrahepatic bile duct Colon and rectum Esophagus Lung and bronchus Pancreas Cancer Sites in Men for Which African American Death Rates* Exceed White Death Rates*, US, *Per 100,000, age-adjusted to the 2000 US standard population. Source: Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Sciences, National Cancer Institute, Site African AmericanWhite Ratio of African American/White

All sites Stomach Myeloma Uterine cervix Esophagus Uterine corpus Small intestine Larynx Colon and rectum Pancreas Breast Gallbladder Urinary bladder Liver and intrahepatic bile duct Cancer Sites in Women for Which African American Death Rates* Exceed White Death Rates*, US, *Per 100,000, age-adjusted to the 2000 US standard population. Source: Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Sciences, National Cancer Institute, Site African AmericanWhite Ratio of African American/White

* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical Research and Applications Branch, NCI, Lifetime Probability of Developing Cancer, Men, * † All Sites exclude basal and squamous cell skin cancers and in situ cancers except urinary bladder. SiteRisk All sites † 1 in 2 Prostate 1 in 6 Lung and bronchus1 in 13 Colon and rectum1 in 18 Urinary bladder ‡ 1 in 27 Melanoma § 1 in 39 Non-Hodgkin lymphoma1 in 45 Kidney1 in 57 Leukemia1 in 67 Oral Cavity1 in 72 Stomach1 in 90 ‡ Includes invasive and in situ cancer cases § Statistic for white men.

Lifetime Probability of Developing Cancer, Women, US, * SiteRisk All sites † 1 in 3 Breast 1 in 8 Lung & bronchus 1 in 16 Colon & rectum 1 in 20 Uterine corpus 1 in 40 Non-Hodgkin lymphoma 1 in 53 Urinary bladder ‡ 1 in 84 Melanoma § 1 in 58 Ovary 1 in 72 Pancreas 1 in 75 Uterine cervix 1 in 145 Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical Research and Applications Branch, NCI, * For those free of cancer at beginning of age interval. † All Sites exclude basal and squamous cell skin cancers and in situ cancers except urinary bladder. ‡ Includes invasive and in situ cancer cases § Statistic for white women.

All Sites Breast (female) Colon Esophagus Leukemia Non-Hodgkin lymphoma Oral cavity Prostate Rectum Urinary bladder Uterine cervix Uterine corpus Cancer Survival*(%) by Race, *5-year relative survival rates based on cancer patients diagnosed from 1996 to 2004 and followed through Source: Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Sciences, National Cancer Institute, Site White Absolute Difference African American

Trends in Five-year Relative Survival (%)* Rates, US, *5-year relative survival rates based on follow up of patients through Source: Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Sciences, National Cancer Institute, Site All sites Breast (female) Colon Leukemia Lung and bronchus Melanoma Non-Hodgkin lymphoma Ovary Pancreas33 5 Prostate Rectum Urinary bladder747881

Tobacco Use in the US, *Age-adjusted to 2000 US standard population. Source: Death rates: US Mortality Data, , US Mortality Volumes, , National Center for Health Statistics, Centers for Disease Control and Prevention, Cigarette consumption: US Department of Agriculture, Per capita cigarette consumption Male lung cancer death rate Female lung cancer death rate

Trends in Cigarette Smoking Prevalence* (%), by Sex, Adults 18 and Older, US, *Redesign of survey in 1997 may affect trends. Source: National Health Interview Survey, , National Center for Health Statistics, Centers for Disease Control and Prevention, Men Women

Trends in Obesity* Prevalence (%), Children and Adolescents, by Age Group, US, *Body mass index (BMI) at or above the sex-and age-specific 95 th percentile BMI cutoff points from the 2000 sex- specific BMI-for-age CDC Growth Charts. Note: Previous editions of Cancer Statistics used the term “overweight” to describe youth in this BMI category. Source: National Health and Nutrition Examination Survey, , , , , National Center for Health Statistics, Centers for Disease Control and Prevention, 2002, : Ogden CL, et al. High Body Mass Index for Age among US Children and Adolescents, JAMA 2008; 299 (20):

Trends in Obesity* Prevalence (%), By Gender, Adults Aged 20 to 74, US, † *Obesity is defined as a body mass index of 30 kg/m 2 or greater. † Age adjusted to the 2000 US standard population. Source: National Health Examination Survey , National Health and Nutrition Examination Survey, , , , , National Center for Health Statistics, Centers for Disease Control and Prevention, 2002, , : National Health and Nutrition Examination Survey Public Use Data Files, , , National Center for Health Statistics, Centers for Disease Control and Prevention, 2006, 2007.

Trends in Obesity* Prevalence (%), By Gender, Adults Aged 20 to 74, US, † *Obesity is defined as a body mass index of 30 kg/m 2 or greater. † Age adjusted to the 2000 US standard population. Source: National Health Examination Survey , National Health and Nutrition Examination Survey, , , , , National Center for Health Statistics, Centers for Disease Control and Prevention, 2002, , : National Health and Nutrition Examination Survey Public Use Data Files, , , National Center for Health Statistics, Centers for Disease Control and Prevention, 2006, 2007.

Trends in Overweight* Prevalence (%), Adults 18 and Older, US, Less than 50%50 to 55%More than 55%State did not participate in survey *Body mass index of 25.0 kg/m 2 or greater. Source: Behavioral Risk Factor Surveillance System, CD-ROM ( , 1998) and Public Use Data Tape ( ), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1997, 2000, 2005, 2007,

Screening Guidelines for the Early Detection of Breast Cancer, American Cancer Society  Yearly mammograms are recommended starting at age 40.  A clinical breast exam should be part of a periodic health examination, about every 3 years for women in their 20s and 30s. Asymptomatic women aged 40 and older should continue to undergo a clinical breast exam, preferably annually*.  Beginning in their early 20s, women should be told about the benefits and limitations of breast-self examination. Women should know how their breasts normally feel and report any breast changes promptly to their health care providers. __________ * Beginning at age 40 years, annual CBE should be performed prior to mammography

Mammogram Prevalence (%), by Educational Attainment and Health Insurance Status, Women 40 and Older, US, *A mammogram within the past year. Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Source: Behavior Risk Factor Surveillance System CD-ROM ( , , 1998, 1999) and Public Use Data Tape (2000, 2002, 2004, 2006), National Centers for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1997, 1999, 2000, 2000, 2001, 2003, 2005, Women with less than a high school education Women with no health insurance All women 40 and older

Screening Guidelines for the Early Detection of Cervical Cancer, American Cancer Society  Screening should begin approximately three years after a women begins having vaginal intercourse, but no later than 21 years of age.  Screening should be done every year with regular Pap tests or every two years using liquid-based tests.  At or after age 30, women who have had three normal test results in a row may get screened every 2-3 years with cervical cytology (either conventional or liquid-based Pap test) alone, or every 3 years with a human papillomavirus DNA test plus cervical cytology.  Women 70 and older who have had three or more consecutive Pap tests in the last ten years may choose to stop cervical cancer screening.  Screening after a total hysterectomy (with removal of the cervix) is not necessary unless the surgery was done as a treatment for cervical cancer.

Trends in Recent* Pap Test Prevalence (%), by Educational Attainment and Health Insurance Status, Women 18 and Older, US, * A Pap test within the past three years. Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Educational attainment is for women 25 and older. Source: Behavior Risk Factor Surveillance System CD-ROM ( , , 1998, 1999) and Public Use Data Tape (2000, 2002, 2004, 2006), National Center for Chronic Disease Prevention and Health Promotion, Center for Disease Control and Prevention, 1997, 1999, 2000, 2000, 2001, 2003, 2005, Women with no health insurance Women with less than a high school education All women 18 and older

Screening Guidelines for the Early Detection of Colorectal Cancer and Adenomas, American Cancer Society 2008 Beginning at age 50, men and women should follow one of the following examination schedules:  A flexible sigmoidoscopy (FSIG) every five years  A colonoscopy every ten years  A double-contrast barium enema every five years  A Computerized Tomographic (CT) colonography every five years  A guaiac-based fecal occult blood test (FOBT) or a fecal immunochemical test (FIT) every year  A stool DNA test (interval uncertain)  Tests that detect adenomatous polyps and cancer  Tests that primarily detect cancer People who are at moderate or high risk for colorectal cancer should talk with a doctor about a different testing schedule

Trends in Recent* Fecal Occult Blood Test Prevalence (%), by Educational Attainment and Health Insurance Status, Adults 50 Years and Older, US, *A fecal occult blood test within the past year. Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Source: Behavioral Risk Factor Surveillance System CD-ROM ( , 1999) and Public Use Data Tape (2001, 2002, 2004, 2006), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention and Prevention, 1999, 2000, 2002, 2003, 2005, 2007.

Trends in Recent* Flexible Sigmoidoscopy or Colonoscopy Prevalence (%), by Educational Attainment and Health Insurance Status, Adults 50 Years and Older, US, *A flexible sigmoidoscopy or colonoscopy within the past ten years. Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Source: Behavioral Risk Factor Surveillance System CD-ROM ( , 1999) and Public Use Data Tape (2001, 2002, 2004, 2006), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention and Prevention, 1999, 2000, 2002, 2003, 2005, 2007.

Screening Guidelines for the Early Detection of Prostate Cancer, American Cancer Society  Beginning at age 50, to men who have a life expectancy of at least 10 years, health care providers should discuss the potential benefits and limitations of prostate cancer early detection testing with men and offer the PSA blood test and the digital rectal examination.* ___________ * Information should be provided to men regarding the benefits and limitations of testing so that an informed decision concerning testing can be made with the clinician’s assistance.

Recent* Prostate-Specific Antigen (PSA) Test Prevalence (%), by Educational Attainment and Health Insurance Status, Men 50 Years and Older, US, *A prostate-specific antigen (PSA) test within the past year. Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Source: Behavioral Risk Factor Surveillance System Public Use Data Tape (2001, 2002, 2004, 2006), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2002, 2003, 2005, 2007.

Recent* Digital Rectal Examination (DRE) Prevalence (%), by Educational Attainment and Health Insurance Status, Men 50 Years and Older, US, *A digital rectal examination (DRE) within the past year. Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Source: Behavioral Risk Factor Surveillance System Public Use Data Tape (2001, 2002, 2004, 2006), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2002, 2003, 2005, 2007.

Resources American Cancer Society Cancer Facts & Figures